lithocholic acid has been researched along with Bowel Diseases, Inflammatory in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Avila-Pacheco, J; Bae, S; Bisanz, JE; Clish, CB; D'Agostino, GD; Devlin, AS; Franzosa, EA; Huh, JR; Huttenhower, C; Kim, E; Krout, MR; Longman, RS; Paik, D; Rakowski, CK; Rastinejad, F; Turnbaugh, PJ; Vlamakis, H; Xavier, RJ; Yao, L; Zhang, M; Zhang, Y | 1 |
| Curley, C; Fallon, CM; Keely, SJ; Lajczak-McGinley, NK; McCarron, PA; Porru, E; Roda, A; Smyth, J; Tambuwala, MM | 1 |
2 other study(ies) available for lithocholic acid and Bowel Diseases, Inflammatory
| Article | Year |
|---|---|
Human gut bacteria produce Τ
Topics: Bacteria; Bile Acids and Salts; Cell Differentiation; Gastrointestinal Tract; Humans; Inflammatory Bowel Diseases; Interleukin-17; Lithocholic Acid; Th17 Cells | 2022 |
The secondary bile acids, ursodeoxycholic acid and lithocholic acid, protect against intestinal inflammation by inhibition of epithelial apoptosis.
Topics: Animals; Apoptosis; Cholagogues and Choleretics; Detergents; Disease Models, Animal; Inflammatory Bowel Diseases; Intestinal Mucosa; Lithocholic Acid; Male; Mice; Mice, Inbred C57BL; Permeability; Protective Agents; Ursodeoxycholic Acid | 2020 |